<i>In Vivo</i> Study on the Therapeutic Potential of <i>Nothapodytes nimmoniana</i> (J. Graham) Mabb. in DHEA-induced Polycystic Ovary Syndrome in Female Albino Mice

Background: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, characterised by elevated androgen levels, chronic inflammation, and oxidative stress. Conventional therapies for PCOS, such as hormonal drugs and insulin sensitisers, often pose side effects and may not fully address the complex nature of the disorder. In recent years, there has been a growing interest in herbal medicine as a safer and more holistic alternative. Aim: The present study aims to evaluate the therapeutic potential of Nothapodytes nimmoniana methanolic leaf extract in the management of PCOS induced by Dehydroepiandrosterone (DHEA) in female albino mice, with a focus on its impact on reproductive, hormonal, and histopathological parameters. Methods: The investigation focused on the effects of its methanolic leaf extract of N. nimmoniana (MLENN), a medicinal plant of significant ethnobotanical value, on hormonal balance, antioxidant status, and the histoarchitecture of ovarian and uterine tissues in a DHEA-induced PCOS mice model. Female albino mice received MLENN at 200 and 400 mg/kg body weight for 20 days, with clomiphene citrate as the standard drug. Hormonal levels (LH, FSH, estrogen, progesterone, testosterone), antioxidant enzymes (SOD, CAT, GPX) and tissue morphology were assessed using histological and Scanning Electron Microscopy (SEM) techniques. Results: This study highlights the potential of N. nimmoniana as a promising natural resource for addressing PCOS through a multi-pronged approach involving significant reduction in serum LH, estrogen, and testosterone levels while increasing FSH and progesterone (p<0.05). PCOS-induced mice showed restored oestrous cyclicity and enhanced antioxidant activity (SOD, CAT, GPX). Histological and SEM analyses revealed reduced cyst formation, thinner theca layers, increased corpora lutea, thicker granulosa layers, and normalisation of uterine histoarchitecture. The 400 mg/kg MLENN dose showed t

View article page

Download PDF